Literature DB >> 28754664

Identification of a Human Airway Epithelial Cell Subpopulation with Altered Biophysical, Molecular, and Metastatic Properties.

Paul C Pagano1, Linh M Tran2,3, Nawal Bendris4, Sean O'Byrne5, Henry T Tse5, Shivani Sharma6,7, Jonathan W Hoech2,3, Stacy J Park2,3, Elvira L Liclican2,3, Zhe Jing2,3, Rui Li1, Kostyantyn Krysan2,3, Manash K Paul2,3, Yari Fontebasso2,3, Jill E Larsen8, Shaina Hakimi2,3, Atsuko Seki9, Michael C Fishbein9, James K Gimzewski6,7, Dino Di Carlo5,7,10, John D Minna11, Tonya C Walser2,3, Steven M Dubinett12,2,3,7,9,10,13.   

Abstract

Lung cancers are documented to have remarkable intratumoral genetic heterogeneity. However, little is known about the heterogeneity of biophysical properties, such as cell motility, and its relationship to early disease pathogenesis and micrometastatic dissemination. In this study, we identified and selected a subpopulation of highly migratory premalignant airway epithelial cells that were observed to migrate through microscale constrictions at up to 100-fold the rate of the unselected immortalized epithelial cell lines. This enhanced migratory capacity was found to be Rac1-dependent and heritable, as evidenced by maintenance of the phenotype through multiple cell divisions continuing more than 8 weeks after selection. The morphology of this lung epithelial subpopulation was characterized by increased cell protrusion intensity. In a murine model of micrometastatic seeding and pulmonary colonization, the motility-selected premalignant cells exhibit both enhanced survival in short-term assays and enhanced outgrowth of premalignant lesions in longer-term assays, thus overcoming important aspects of "metastatic inefficiency." Overall, our findings indicate that among immortalized premalignant airway epithelial cell lines, subpopulations with heritable motility-related biophysical properties exist, and these may explain micrometastatic seeding occurring early in the pathogenesis of lung cancer. Understanding, targeting, and preventing these critical biophysical traits and their underlying molecular mechanisms may provide a new approach to prevent metastatic behavior. Cancer Prev Res; 10(9); 514-24. ©2017 AACRSee related editorial by Hynds and Janes, p. 491. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28754664      PMCID: PMC5584580          DOI: 10.1158/1940-6207.CAPR-16-0335

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  47 in total

Review 1.  Crossing the endothelial barrier during metastasis.

Authors:  Nicolas Reymond; Bárbara Borda d'Água; Anne J Ridley
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

2.  The regulatory role of cell mechanics for migration of differentiating myeloid cells.

Authors:  Franziska Lautenschläger; Stephan Paschke; Stefan Schinkinger; Arlette Bruel; Michael Beil; Jochen Guck
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

3.  A sensitive polymerase chain reaction-based method for detection and quantification of metastasis in human xenograft mouse models.

Authors:  Anastasia Malek; Carlo V Catapano; Frank Czubayko; Achim Aigner
Journal:  Clin Exp Metastasis       Date:  2010-04-04       Impact factor: 5.150

4.  A novel molecular pathway for Snail-dependent, SPARC-mediated invasion in non-small cell lung cancer pathogenesis.

Authors:  Jeanette L Grant; Michael C Fishbein; Long-Sheng Hong; Kostyantyn Krysan; John D Minna; Jerry W Shay; Tonya C Walser; Steven M Dubinett
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-19

5.  Inhibition of the GTPase Rac1 mediates the antimigratory effects of metformin in prostate cancer cells.

Authors:  Béatrice Dirat; Isabelle Ader; Muriel Golzio; Fabienne Massa; Amel Mettouchi; Kathiane Laurent; Frédéric Larbret; Bernard Malavaud; Mireille Cormont; Emmanuel Lemichez; Olivier Cuvillier; Jean François Tanti; Frédéric Bost
Journal:  Mol Cancer Ther       Date:  2014-12-19       Impact factor: 6.261

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

8.  High expression of DNA repair pathways is associated with metastasis in melanoma patients.

Authors:  A Kauffmann; F Rosselli; V Lazar; V Winnepenninckx; A Mansuet-Lupo; P Dessen; J J van den Oord; A Spatz; A Sarasin
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

9.  Nanomechanical analysis of cells from cancer patients.

Authors:  Sarah E Cross; Yu-Sheng Jin; Jianyu Rao; James K Gimzewski
Journal:  Nat Nanotechnol       Date:  2007-12-02       Impact factor: 39.213

Review 10.  Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency.

Authors:  A F Chambers; G N Naumov; S A Vantyghem; A B Tuck
Journal:  Breast Cancer Res       Date:  2000-07-21       Impact factor: 6.466

View more
  3 in total

1.  Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non-Small Cell Lung Cancer.

Authors:  Rui Li; Ramin Salehi-Rad; William Crosson; Milica Momcilovic; Raymond J Lim; Stephanie L Ong; Zi Ling Huang; Tianhao Zhang; Jensen Abascal; Camelia Dumitras; Zhe Jing; Stacy J Park; Kostyantyn Krysan; David B Shackelford; Linh M Tran; Bin Liu; Steven M Dubinett
Journal:  Cancer Res       Date:  2021-04-14       Impact factor: 12.701

Review 2.  Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories.

Authors:  Robert E Hynds; Kristopher K Frese; David R Pearce; Eva Grönroos; Caroline Dive; Charles Swanton
Journal:  Open Biol       Date:  2021-01-13       Impact factor: 6.411

Review 3.  Notch Transduction in Non-Small Cell Lung Cancer.

Authors:  Amnah Sharif; Ann Shaji; May Chammaa; Eileen Pawlik; Rodrigo Fernandez-Valdivia
Journal:  Int J Mol Sci       Date:  2020-08-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.